{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:27Z","timestamp":1791576147850,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The histone deacetylase (HDAC) has recently been linked to the morphogenesis and virulence of yeast. However, the effects of HDAC on antifungal susceptibility are not well understood. We sought to characterize the action of histone deacetylation on azole resistance in Candida albicans and its possible mechanism of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 40 C. albicans strains were studied. Azole susceptibility with or without trichostatin A (TSA) was determined according to the CLSI microdilution method. The null mutants of HDA1 and RPD3 (genes targeted by TSA) were also investigated using drop-plate assays and a rapid acquisition of adaptation to the azole test. Transcriptional levels of HDAC genes and efflux genes were quantified using RT\u2013PCR for both the basal and fluconazole-induced conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The inhibition of HDACs by TSA (0.25 mg\/L) markedly reduced the trailing growth and the growth of most C. albicans strains. Trailing growth for C. albicans strains was decreased from 2-fold to 256-fold at 48 h. The deletion of HDA1 or RPD3 increased the susceptibility to azoles compared with the WT strain. The expression of HDA1 and RPD3 was up-regulated to different levels, and returned to the level of the susceptible parental strain when stable resistance had formed during the course of acquired fluconazole resistance both in vitro and in vivo. Efflux genes were poorly expressed in mutant strains compared with those of the WT strain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicate the important role of the Rpd3\/Hda1 family in the development of azole resistance in C. albicans. Histone deacetylation may govern the expression of genes related to the early stages of adaptation to azole stress, such as efflux pump genes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkv070","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T12:59:26Z","timestamp":1427806766000},"page":"1993-2003","source":"Crossref","is-referenced-by-count":63,"title":["The Rpd3\/Hda1 family of histone deacetylases regulates azole resistance in\n                    <i>Candida albicans<\/i>"],"prefix":"10.1093","volume":"70","author":[{"given":"Xiaofang","family":"Li","sequence":"first","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cai","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"},{"name":"3 \u00a0Fungal Reference Laboratory, Shanghai Dermatology Hospital, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Mei","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhou","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongnian","family":"Shen","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"},{"name":"4 \u00a0Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Liu","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China"},{"name":"2 \u00a0Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,29]]},"reference":[{"key":"2022020121023183200_DKV070C1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bjh.12896","article-title":"Current status of antifungal resistance and its impact on clinical practice","volume":"166","author":"Alcazar-Fuoli","year":"2014","journal-title":"Br J Haematol"},{"key":"2022020121023183200_DKV070C2","doi-asserted-by":"crossref","first-page":"e99103","DOI":"10.1371\/journal.pone.0099103","article-title":"Epidemiology and prognostic factors of candidemia in cancer patients","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS One"},{"key":"2022020121023183200_DKV070C3","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jac\/dkt083","article-title":"Invasive candidiasis in intensive care units in China: a multicentre prospective observational study","volume":"68","author":"Guo","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2022020121023183200_DKV070C4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","article-title":"Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation","volume":"9","author":"Sanglard","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"2022020121023183200_DKV070C5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1130-1406(08)70027-5","article-title":"Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi","volume":"25","author":"Espinel-Ingroff","year":"2008","journal-title":"Rev Iberoam Micol"},{"key":"2022020121023183200_DKV070C6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jac\/dks186","article-title":"Amino acid substitutions in the Candida albicans sterol \u03945,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence","volume":"67","author":"Morio","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2022020121023183200_DKV070C7","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","article-title":"Comparison of visual and spectrophotometric methods of broth microdilution MIC endpoint determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates","volume":"46","author":"Arthington-Skaggs","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121023183200_DKV070C8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1439-0507.2006.01329.x","article-title":"Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study","volume":"50","author":"Lee","year":"2007","journal-title":"Mycoses"},{"key":"2022020121023183200_DKV070C9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jac\/dkh040","article-title":"Drug resistance genes and trailing growth in Candida albicans isolates","volume":"53","author":"Lee","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2022020121023183200_DKV070C10","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1128\/MCB.19.11.7816","article-title":"HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor","volume":"19","author":"Wang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2022020121023183200_DKV070C11","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1073\/pnas.95.6.2795","article-title":"Characterization of a human RPD3 ortholog, HDAC3","volume":"95","author":"Emiliani","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020121023183200_DKV070C12","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020121023183200_DKV070C13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022020121023183200_DKV070C14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cca.2010.06.020","article-title":"Role of histone acetylation in cell physiology and diseases: an update","volume":"411","author":"Khan","year":"2010","journal-title":"Clin Chim Acta"},{"key":"2022020121023183200_DKV070C15","doi-asserted-by":"crossref","first-page":"13708","DOI":"10.1073\/pnas.250477697","article-title":"Genomewide studies of histone deacetylase function in yeast","volume":"97","author":"Bernstein","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020121023183200_DKV070C16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.20200","article-title":"Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives","volume":"32","author":"Pontiki","year":"2012","journal-title":"Med Res Rev"},{"key":"2022020121023183200_DKV070C17","doi-asserted-by":"crossref","first-page":"15837","DOI":"10.1074\/jbc.271.26.15837","article-title":"HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex","volume":"271","author":"Carmen","year":"1996","journal-title":"J Biol Chem"},{"key":"2022020121023183200_DKV070C18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","article-title":"A novel histone deacetylase inhibitor chidamide induces apoptosis of human colon cancer cells","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"2022020121023183200_DKV070C19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin Epigenetics"},{"key":"2022020121023183200_DKV070C20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/157488410791498770","article-title":"Role of histone deacetylases and their inhibitors in cancer biology and treatment","volume":"5","author":"Beumer","year":"2010","journal-title":"Curr Clin Pharmacol"},{"key":"2022020121023183200_DKV070C21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Disc"},{"key":"2022020121023183200_DKV070C22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"2022020121023183200_DKV070C23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/13543784.2011.546218","article-title":"Tumor heterogeneity and strategies to overcome kinase inhibitor resistance in cancer: lessons from melanoma","volume":"20","author":"Rebecca","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"2022020121023183200_DKV070C24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.2175","article-title":"Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy","volume":"16","author":"Wurtele","year":"2010","journal-title":"Nat Med"},{"key":"2022020121023183200_DKV070C25","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/AAC.46.11.3532-3539.2002","article-title":"Histone deacetylase inhibitors enhance Candida albicans susceptibility to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation","volume":"46","author":"Smith","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121023183200_DKV070C26","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2022020121023183200_DKV070C27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bmcl.2006.12.028","article-title":"Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans","volume":"17","author":"Mai","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"2022020121023183200_DKV070C28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fgb.2009.08.002","article-title":"Regulation of multidrug resistance in pathogenic fungi","volume":"47","author":"Morschh\u00e4user","year":"2010","journal-title":"Fungal Genet Biol"},{"key":"2022020121023183200_DKV070C29","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/JB.183.15.4614-4625.2001","article-title":"The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans","volume":"183","author":"Srikantha","year":"2001","journal-title":"J Bacteriol"},{"issue":"Suppl 1","key":"2022020121023183200_DKV070C30","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1111\/j.1601-0825.1997.tb00336.x","article-title":"Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient","volume":"3","author":"White","year":"1997","journal-title":"Oral Dis"},{"key":"2022020121023183200_DKV070C31","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.41.7.1488","article-title":"The presence of an R467 K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121023183200_DKV070C32","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"2022020121023183200_DKV070C33","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement M27-S4","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"2022020121023183200_DKV070C34","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1021\/pr060656c","article-title":"Proteomic analysis reveals a metabolism shift in a laboratory fluconazole-resistant Candida albicans strain","volume":"6","author":"Yan","year":"2007","journal-title":"J Proteome Res"},{"key":"2022020121023183200_DKV070C35","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121023183200_DKV070C36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.330.6004.611","article-title":"Epigenetics. What is epigenetics? Introduction","volume":"330","author":"Riddihough","year":"2010","journal-title":"Science"},{"key":"2022020121023183200_DKV070C37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1191078","article-title":"Molecular signals of epigenetic states","volume":"330","author":"Bonasio","year":"2010","journal-title":"Science"},{"key":"2022020121023183200_DKV070C38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ng.286","article-title":"DNA methylation profiles in monozygotic and dizygotic twins","volume":"41","author":"Kaminsky","year":"2009","journal-title":"Nat Genet"},{"key":"2022020121023183200_DKV070C39","doi-asserted-by":"crossref","first-page":"e1000889","DOI":"10.1371\/journal.ppat.1000889","article-title":"The Set3\/Hos2 histone deacetylase complex attenuates cAMP\/PKA signaling to regulate morphogenesis and virulence of Candida albicans","volume":"6","author":"Hnisz","year":"2010","journal-title":"PLoS Pathog"},{"key":"2022020121023183200_DKV070C40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/genetics\/158.2.919","article-title":"A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans","volume":"158","author":"Klar","year":"2001","journal-title":"Genetics"},{"key":"2022020121023183200_DKV070C41","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1567-1364.2007.00276.x","article-title":"Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans","volume":"7","author":"Simonetti","year":"2007","journal-title":"FEMS Yeast Res"},{"key":"2022020121023183200_DKV070C42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.2009.06772.x","article-title":"Transcriptional loops meet chromatin: a dual-layer network controls white-opaque switching in Candida albicans","volume":"74","author":"Hnisz","year":"2009","journal-title":"Mol Microbiol"},{"key":"2022020121023183200_DKV070C43","doi-asserted-by":"crossref","first-page":"e1003118","DOI":"10.1371\/journal.pgen.1003118","article-title":"A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis","volume":"8","author":"Hnisz","year":"2012","journal-title":"PLoS Genet"},{"key":"2022020121023183200_DKV070C44","doi-asserted-by":"crossref","first-page":"e12171","DOI":"10.1371\/journal.pone.0012171","article-title":"HOS2 and HDA1 encode histone deacetylases with opposing roles in Candida albicans morphogenesis","volume":"5","author":"Zacchi","year":"2010","journal-title":"PLoS One"},{"key":"2022020121023183200_DKV070C45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0022-2836(03)00505-9","article-title":"Adaptation of the Efg1p morphogenetic pathway in Candida albicans by negative autoregulation and PKA-dependent repression of the EFG1 gene","volume":"329","author":"Tebarth","year":"2003","journal-title":"J Mol Biol"},{"key":"2022020121023183200_DKV070C46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1248\/bpb.30.68","article-title":"Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction","volume":"30","author":"Shen","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"2022020121023183200_DKV070C47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijantimicag.2013.07.013","article-title":"Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans","volume":"42","author":"Morio","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2022020121023183200_DKV070C48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.celrep.2012.08.035","article-title":"Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance","volume":"2","author":"Robbins","year":"2012","journal-title":"Cell Rep"},{"key":"2022020121023183200_DKV070C49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mib.2013.03.005","article-title":"The fungal Achilles' heel: targeting Hsp90 to cripple fungal pathogens","volume":"16","author":"Cowen","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"2022020121023183200_DKV070C50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.05290-11","article-title":"Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm","volume":"56","author":"Yu","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/7\/1993\/42354971\/jac_70_7_1993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/7\/1993\/42354971\/jac_70_7_1993.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T16:16:08Z","timestamp":1643732168000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/70\/7\/1993\/776696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,29]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,3,29]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv070","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,7]]},"published":{"date-parts":[[2015,3,29]]}}}